Most large cryptocurrencies were up during U.S. morning trading on Monday, with Cardano Cardano USD seeing the biggest change, climbing 9.04% to 27 cents. Six additional currencies posted raises ...

Synopsys entered into an accelerated share repurchase agreement with JPMorgan Chase to buy $1 billion worth of its stock. The chip-design software company on Monday said it expects to initially ...

Navitas Semiconductor and Microchip Technology worked together to make a reference design aimed at artificial-intelligence data centers.

"Approval of the Mining and Closure Plans is a defining milestone for Tanbreez and for Critical Metals," Chief Executive Tony Sage said. "It gives us a clear framework through 2050 to responsibly ...

Flex agreed to sell $2 billion in convertible preferred stock of Axiom Solutions International, its cloud and power-infrastructure segment, as it prepares to spin off the business. Flex said Monday ...

She developed pleural effusion — fluid between the lungs and ribs — compressing her lungs and making it hard for her to ...

Nutrien previously launched a controlled shutdown of the facility in late October in response to port access restrictions and a lack of reliable and economic natural gas supply, which it said had ...

Under the revised terms, Aurora shareholders would receive a total consideration of $5.00 a share, made up of 0.4013 Curaleaf shares and $1.00 in cash, implying a deal worth $324.2 million.

The companies had announced plans back in June for Neighborhood Intelligence, then known as Bed Bath & Beyond, to acquire real estate services platform Fathom for about $53.4 mill ...

Retension Pharmaceuticals plans to sell 3.3 million shares at between $11 and $13 each in its initial public offering.

Crescent Biopharma said the Food and Drug Administration cleared its investigational new drug application for CR-002 to treat advanced solid tumors. Chief Medical Officer Ellie Im on Monday said the ...

Alector entered into an exclusive global licensing agreement with Genetech, which will receive worldwide rights to develop and commercialize Alector's AL050 program.